MA29154B1 - Promedicament amide de gemcitabine, compositions et utilisations associees - Google Patents

Promedicament amide de gemcitabine, compositions et utilisations associees

Info

Publication number
MA29154B1
MA29154B1 MA30079A MA30079A MA29154B1 MA 29154 B1 MA29154 B1 MA 29154B1 MA 30079 A MA30079 A MA 30079A MA 30079 A MA30079 A MA 30079A MA 29154 B1 MA29154 B1 MA 29154B1
Authority
MA
Morocco
Prior art keywords
compositions
promedicament
gemcitabine amide
gemcitabine
amide
Prior art date
Application number
MA30079A
Other languages
English (en)
French (fr)
Inventor
David Michael Bender
David Michael Remick
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MA29154B1 publication Critical patent/MA29154B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/073Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
MA30079A 2004-12-17 2007-07-13 Promedicament amide de gemcitabine, compositions et utilisations associees MA29154B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63742204P 2004-12-17 2004-12-17

Publications (1)

Publication Number Publication Date
MA29154B1 true MA29154B1 (fr) 2008-01-02

Family

ID=36168678

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30079A MA29154B1 (fr) 2004-12-17 2007-07-13 Promedicament amide de gemcitabine, compositions et utilisations associees

Country Status (31)

Country Link
US (1) US7691827B2 (cg-RX-API-DMAC7.html)
EP (1) EP1831237B1 (cg-RX-API-DMAC7.html)
JP (1) JP5022911B2 (cg-RX-API-DMAC7.html)
KR (1) KR100874052B1 (cg-RX-API-DMAC7.html)
CN (1) CN101080417B (cg-RX-API-DMAC7.html)
AR (1) AR055009A1 (cg-RX-API-DMAC7.html)
AT (1) ATE405573T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005316922B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0519117A2 (cg-RX-API-DMAC7.html)
CA (1) CA2589850C (cg-RX-API-DMAC7.html)
CY (1) CY1108447T1 (cg-RX-API-DMAC7.html)
DE (1) DE602005009255D1 (cg-RX-API-DMAC7.html)
DK (1) DK1831237T3 (cg-RX-API-DMAC7.html)
EA (1) EA011868B1 (cg-RX-API-DMAC7.html)
ES (1) ES2310860T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20080529T3 (cg-RX-API-DMAC7.html)
IL (1) IL183666A (cg-RX-API-DMAC7.html)
MA (1) MA29154B1 (cg-RX-API-DMAC7.html)
MX (1) MX2007007228A (cg-RX-API-DMAC7.html)
MY (1) MY143677A (cg-RX-API-DMAC7.html)
NO (1) NO20073368L (cg-RX-API-DMAC7.html)
NZ (1) NZ554732A (cg-RX-API-DMAC7.html)
PE (1) PE20060771A1 (cg-RX-API-DMAC7.html)
PL (1) PL1831237T3 (cg-RX-API-DMAC7.html)
PT (1) PT1831237E (cg-RX-API-DMAC7.html)
RS (1) RS50629B (cg-RX-API-DMAC7.html)
SI (1) SI1831237T1 (cg-RX-API-DMAC7.html)
TW (1) TWI326687B (cg-RX-API-DMAC7.html)
UA (1) UA86119C2 (cg-RX-API-DMAC7.html)
WO (1) WO2006065525A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200705019B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA014909B1 (ru) * 2006-06-21 2011-02-28 Эли Лилли Энд Компани Кристаллические формы пролекарства на основе амида гемцитабина, композиции на их основе и их применение
TWI436775B (zh) 2007-08-24 2014-05-11 Oncotherapy Science Inc 以抗原胜肽合併化療藥劑治療胰臟癌
CN101525361B (zh) 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
CN102432654A (zh) * 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
CN104955458A (zh) 2012-11-07 2015-09-30 Z·索 取代的吉西他滨芳基酰胺类似物和使用所述类似物的治疗方法
WO2014078295A1 (en) 2012-11-13 2014-05-22 BoYen Therapeutics, Inc. Gemcitabine prodrugs and uses thereof
EP3119795A4 (en) * 2014-03-03 2018-03-14 Nucorion Pharmaceuticals, Inc. Gemcitabine analogs
WO2016078160A1 (zh) * 2014-11-17 2016-05-26 常州方圆制药有限公司 胞苷衍生物及其应用
US10435429B2 (en) 2017-10-03 2019-10-08 Nucorion Pharmaceuticals, Inc. 5-fluorouridine monophosphate cyclic triester compounds
KR102708995B1 (ko) 2018-01-10 2024-09-23 누코리온 파마슈티컬스, 인코포레이티드. 포스포르(포스포론)아미다타세탈 및 포스프(온)아탈세탈 화합물
US11427550B2 (en) 2018-01-19 2022-08-30 Nucorion Pharmaceuticals, Inc. 5-fluorouracil compounds
KR20200118827A (ko) 2018-02-02 2020-10-16 마베릭스 온콜로지, 잉크. 젬시타빈 모노포스페이트의 소분자 약물 컨쥬게이트
JP7598313B2 (ja) * 2018-04-26 2024-12-11 ナノメッド ホールディングス プロプライエタリー リミテッド ジェムシタビン両親媒性プロドラッグ
CN108864250A (zh) * 2018-05-29 2018-11-23 北京大学 一种FAPα酶敏感的吉西他滨前体药物及其制备方法和应用
AU2019313484A1 (en) * 2018-08-03 2021-02-18 Cellix Bio Private Limited Compositions and methods for the treatment of cancer
KR20220035143A (ko) 2019-07-17 2022-03-21 누코리온 파마슈티컬스, 인코포레이티드. 사이클릭 디옥시리보뉴클레오티드 화합물
EP4143199B1 (en) 2020-04-21 2025-11-19 Ligand Pharmaceuticals, Inc. Nucleotide prodrug compounds
PL442924A1 (pl) * 2022-11-23 2024-05-27 Politechnika Śląska Prolek - glikokoniugat pochodny gemcytabiny, jako związek o działaniu przeciwnowotworowym, sposób otrzymywania i zastosowanie

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
RU2131880C1 (ru) * 1992-06-22 1999-06-20 Эли Лилли Энд Компани Способ получения обогащенных бета-аномером нуклеозидов
GB2321454A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Gemcitabine esters and amides
NZ336676A (en) * 1997-01-24 2000-01-28 Norsk Hydro As Gemcitabine esters or amides useful as anti-cancer and anti-viral agents
US6624142B2 (en) * 1997-12-30 2003-09-23 Enzon, Inc. Trimethyl lock based tetrapartate prodrugs
US5965119A (en) * 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6376470B1 (en) * 1999-09-23 2002-04-23 Enzon, Inc. Polymer conjugates of ara-C and ara-C derivatives
EP1567169A4 (en) * 2002-11-04 2009-10-21 Xenoport Inc GEMCITABINE PROMOTERS, THEIR PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
US7846436B2 (en) * 2003-11-28 2010-12-07 Chemgenes Corporation Oligonucleotides and related compounds

Also Published As

Publication number Publication date
UA86119C2 (ru) 2009-03-25
ES2310860T3 (es) 2009-01-16
EA011868B1 (ru) 2009-06-30
TW200634023A (en) 2006-10-01
AU2005316922A1 (en) 2006-06-22
RS50629B (sr) 2010-06-30
KR20070086308A (ko) 2007-08-27
EP1831237A1 (en) 2007-09-12
DE602005009255D1 (de) 2008-10-02
BRPI0519117A2 (pt) 2008-12-23
SI1831237T1 (sl) 2009-02-28
EP1831237B1 (en) 2008-08-20
CN101080417A (zh) 2007-11-28
IL183666A0 (en) 2007-09-20
PE20060771A1 (es) 2006-09-23
AU2005316922B2 (en) 2011-08-25
ATE405573T1 (de) 2008-09-15
HRP20080529T3 (en) 2008-12-31
KR100874052B1 (ko) 2008-12-12
PT1831237E (pt) 2008-09-22
TWI326687B (en) 2010-07-01
US20090156547A1 (en) 2009-06-18
ZA200705019B (en) 2008-10-29
MX2007007228A (es) 2007-08-14
DK1831237T3 (da) 2008-10-27
PL1831237T3 (pl) 2009-01-30
CA2589850C (en) 2012-05-01
JP2008524218A (ja) 2008-07-10
EA200701300A1 (ru) 2007-10-26
JP5022911B2 (ja) 2012-09-12
CA2589850A1 (en) 2006-06-22
NO20073368L (no) 2007-07-16
US7691827B2 (en) 2010-04-06
CY1108447T1 (el) 2014-04-09
MY143677A (en) 2011-06-30
WO2006065525A1 (en) 2006-06-22
AR055009A1 (es) 2007-08-01
NZ554732A (en) 2010-09-30
CN101080417B (zh) 2011-01-19
IL183666A (en) 2011-09-27
HK1109903A1 (en) 2008-06-27

Similar Documents

Publication Publication Date Title
MA29154B1 (fr) Promedicament amide de gemcitabine, compositions et utilisations associees
MA30910B1 (fr) Anticorps et immunoconjugues, et leurs utilisations
TW200732349A (en) Anti-OX40L antibodies and methods using same
EA200701840A1 (ru) N-сульфонилпирролы и их применение в качестве ингибиторов гистондезацетилазы
EP1781593A4 (en) CATIONIC LIPIDS AND USE METHOD
MA31231B1 (fr) Anticorps anti-robo4 et utilisations de ceux-ci
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
EA200701918A1 (ru) Белок липокалин
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
EP1851335A4 (en) COMPOSITIONS AND METHODS FOR USE OF STANDARDIZED MIXTURES
ATE384448T1 (de) Symbiotische zusammensetzung
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
EA201000888A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы в качестве гербицидов
WO2005087724A3 (en) Sulphonylpyrroles as hdac inhibitors
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
EP1948690A4 (en) COMPOSITIONS AND METHODS OF HEMOSTASE MODULATION
EA200801351A1 (ru) Фунгицидные смеси, которые содержат боскалид и пириметанил
TW200744567A (en) Phenylethylamine analogs and their use for treating glaucoma
ATE444990T1 (de) Spritzbare akustikmassen
WO2006086325A3 (en) Synthesis of homopolymers and block copolymers
EP1495759A4 (en) SOLID DISPERSION COMPOSITION
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
BRPI0417205A (pt) composições farmacêuticas
EA200601855A1 (ru) Гербицидоактивные 3-амино-2-тиометилбензоилпиразолы
MA27528A1 (fr) Composes calcilytiques